Clinical features and prognosis of retroperitoneal hemangiosarcoma in dogs with surgical resection with or without adjuvant doxorubicin

被引:1
作者
Ichimata, Masanao [1 ]
Toshima, Atsushi [2 ]
Matsuyama, Fukiko [1 ]
Fukazawa, Eri [1 ]
Harada, Kei [1 ]
Katayama, Ryuzo [1 ]
Kagawa, Yumiko [2 ,3 ]
Yamagami, Tetsushi [2 ]
Kobayashi, Tetsuya [1 ]
机构
[1] Japan Small Anim Med Ctr Fdn, Japan Small Anim Canc Ctr, 1-10-4 Higashi Tokorozawa, Tokorozawa, Saitama 3590023, Japan
[2] Japan Small Anim Med Ctr, Saitama, Japan
[3] North Lab, Sapporo, Hokkaido, Japan
关键词
dog; doxorubicin; hemangiosarcoma; retroperitoneum; surgery; CANINE HEMANGIOSARCOMA; RETROSPECTIVE ANALYSIS; THERAPY;
D O I
10.1292/jvms.22-0533
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
. Retroperitoneal hemangiosarcoma (RPHSA) is a rare tumor in dogs with a poorly understood prognosis after surgery. The objectives of this study were to investigate the clinical features and prognosis of canine RPHSA that had undergone surgical resection. In this single-center, retrospective cohort study, we reviewed the medical records of dogs that had undergone surgical resection for retroperitoneal tumors and received a histopathologic diagnosis of HSA between 2005 and 2021. The median progression-free survival (PFS) and overall survival (OS) were 77.5 days and 168 days, respectively. In the present study, canine RPHSA had an aggressive biological behavior similar to visceral HSA. Further studies in larger canine populations are needed to evaluate the efficacy of adjuvant chemotherapy.
引用
收藏
页码:1231 / 1236
页数:6
相关论文
共 37 条
  • [31] The management of colorectal liver metastases amenable of surgical resection: How to shape treatment strategies according to clinical, radiological, pathological and molecular features
    Germani, Marco Maria
    Borelli, Beatrice
    Boraschi, Piero
    Antoniotti, Carlotta
    Ugolini, Clara
    Urbani, Lucio
    Morelli, Luca
    Fontanini, Gabriella
    Masi, Gianluca
    Cremolini, Chiara
    Moretto, Roberto
    CANCER TREATMENT REVIEWS, 2022, 106
  • [32] Surgical resection for non-small cell lung cancer: clinical features and outcomes for a consecutive series at an Irish tertiary referral centre
    B. S. Al-Alao
    D. S. O’Callaghan
    K. Gately
    S. Nicholson
    L. E. Coate
    F. O’Connell
    E. McGovern
    K. J. O’Byrne
    V. K. Young
    Irish Journal of Medical Science, 2013, 182 : 217 - 225
  • [33] Surgical resection for non-small cell lung cancer: clinical features and outcomes for a consecutive series at an Irish tertiary referral centre
    Al-Alao, B. S.
    O'Callaghan, D. S.
    Gately, K.
    Nicholson, S.
    Coate, L. E.
    O'Connell, F.
    McGovern, E.
    O'Byrne, K. J.
    Young, V. K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 (02) : 217 - 225
  • [34] Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea Spinal Oncology Research Group
    Lee, Sun-Ho
    Chung, Chun Kee
    Kim, Chi Heon
    Yoon, Sang Hoon
    Hyun, Seung-Jae
    Kim, Ki-Jeong
    Kim, Eun-Sang
    Eoh, Whan
    Kim, Hyun-Jib
    NEURO-ONCOLOGY, 2013, 15 (07) : 921 - 929
  • [35] Surgical Approach (Excision and Biopsy) for Intestinal Tumors in Dogs - Part 1: How do Signalment, clinical and pathohistological Findings influence the postoperative Course and Prognosis?
    Mueller, Melanie
    Rohn, Karl
    Fehr, Michael
    Eberle, Nina
    KLEINTIERPRAXIS, 2024, 69 (09):
  • [36] Incidence, Clinical Features, and Association with Prognosis of Bloodstream Infection in Pediatric Patients After Percutaneous or Surgical Treatment for Ventricular Septal Defect or Atrial Septal Defect: A Retrospective Cohort Study
    Chen, Qinchang
    Yu, Jinjin
    Huang, Pingchuan
    Huang, Yulu
    Chen, Qingui
    Zhang, Zhiwei
    Wang, Shushui
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (06) : 2219 - 2232
  • [37] Clinical outcomes and resource utilization after surgical resection with curative intent among patients with non-small cell lung cancer treated with adjuvant therapies in a community oncology setting: A real-world retrospective observational study
    Cai, Beilei
    Fulcher, Nicole
    Boyd, Marley
    Spira, Alexander
    THORACIC CANCER, 2021, 12 (14) : 2055 - 2064